Does spontaneous autoimmunity improve survival in visceral metastatic melanoma? [17]

British Journal of Dermatology

Volumn 157, Issue 2, 2007, Pages 413-415

  Vercambre Darras, S ^a   Dubucquoi, S ^a   Fajardy, I ^a   Piette, F ^a   Mortier, L ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENT COMPONENT C3; HLA A2 ANTIGEN; HLA DR4 ANTIGEN; THYROGLOBULIN ANTIBODY; TUMOR MARKER; TUMOR VACCINE;

AUTOIMMUNITY; CANCER DIAGNOSIS; CANCER STAGING; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; LETTER; MELANOMA; POPULATION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; THYROIDITIS; VISCERAL METASTASIS; VITILIGO;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNITY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS;

EID: 34447538156     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08016.x     Document Type: Letter

References (4)

1. Sosman JA, Unger JM, Liu PY et al. Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome. J Clin Oncol 2002 20 : 2067 75.
2. Gogas H, Ioannovich J, Dafni U et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 2006 354 : 709 18.
3. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002 87 : 489 99.
4. Luongo V, Pirozzi G, Caraco C et al. HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma. Tissue Antigens 2004 64 : 84 7.